Why Med Spa Clients Stop Coming Back

Most med spa clients do not decide to leave. The result fades on a schedule that is already written down, in FDA-approved labeling, in device clearance documents, and by the manufacturers themselves. What almost none of those documents record, and what the industry does not measure, is whether the next appointment was on the calendar before the patient walked out.

That is the whole gap. Not between the client and your marketing. Between a published fade date and an empty diary.

Below is what the labels actually say, product by product, with the source for each. Then the retention statistics circulating in this industry that do not survive being checked, because several of the numbers you have been quoted are not real.

Everything here reports what a document states or what a study population did. None of it is clinical guidance, and nothing here is a recommended treatment interval for any patient. Read on 27 July 2026.

What the neurotoxin labels actually say

Product	What its FDA label states	What the manufacturer markets
BOTOX Cosmetic	"The duration of effect of BOTOX Cosmetic for glabellar lines is approximately 3-4 months." Frown lines only	"May last up to 4 months"
Dysport	"The clinical effect of DYSPORT may last up to four months"	Up to 5 months
Xeomin	"The typical duration of effect of each treatment is up to 12-16 weeks." Label-wide, covering all indications	Approximately 3 to 4 months
Jeuveau	No duration of effect stated anywhere in the label	Up to four months, and separately that patients average three treatments a year
Daxxify	No duration of effect stated in the label	Around six months, from published SAKURA trial medians of 24.0 and 23.9 weeks
Letybo	No duration of effect stated in the label	"Lasting up to 4 months," footnoted to an average time to retreatment of 127 days in its Phase 3 study

FDA-approved prescribing information via DailyMed, and each manufacturer's own site, read 27 July 2026.

Three things in that table are worth more than the numbers.

Only three of six labels state a duration at all. Jeuveau, Daxxify and Letybo state none. Every duration figure you have heard for those three comes from marketing or from published trial data, not from the label.

BOTOX Cosmetic's 3 to 4 months is for frown lines only. The label states no duration for crow's feet, forehead lines or platysma bands. Those sections report efficacy at day 30 and stop. If you have been running a recall interval for crow's feet on the basis of "the label says 3 to 4 months," the label does not say that.

Dysport markets a month longer than its own label. The five-month figure is footnoted to a post-hoc analysis using a one-grade improvement threshold, a weaker endpoint than the two-grade measure the approval rests on. The label and the billboard are not measuring the same thing.

The American Society of Plastic Surgeons and the American Academy of Dermatology both put the category at about three to four months, which is the figure to use when you need one that covers a product or an area whose label states none.

What the filler labels actually say

Fillers are where "how long does it last" gets least useful, because the honest answer is a declining curve rather than a date.

Product	Published figure	The curve behind it
Juvéderm Voluma XC, cheeks	Up to 2 years in a majority of subjects	86.6% at month 9, 85.2% at 12, 71.5% at 18, 67.1% at 24
Juvéderm Vollure XC, nasolabial folds	Improvement through 18 months	93.2% at 6 months, 57.5% at 12, 59.4% at 18
Juvéderm Ultra XC, lips	Through 12 months	80.5% at 6 months, 63.6% at 9, 56.4% at 12
Juvéderm Volbella XC, lips and perioral	Through 1 year	80.3% at 3 months, 71.1% at 6, 65.1% at 9, 61.8% at 12
RHA 2	12 months in 85% of patients, 15 months in 81%	Study ran 64 weeks; no figure exists past 15 months
RHA Redensity, perioral	6 months in 73%, 12 months in 67%	Materially shorter than the rest of its own collection
Restylane Lyft	Up to 1 year in cheeks, up to 6 months in nasolabial folds and hands	A twofold spread inside a single syringe
Radiesse, nasolabial folds	FDA labeling: lasted 1 year after the first session, with effectiveness beyond one year not investigated	Marketed as up to 2 years, footnoted to a study finding 40% of folds improved at 30 months

FDA patient labeling and manufacturers' Directions for Use, read 27 July 2026.

FDA reviewers made the point plainly in their summary for the RHA collection: responder rates "decrease over time for all three formulations, indicating an expected loss of treatment effect." The published month is the end of a slope, not a plateau with a cliff at the end.

Which is why Restylane Lyft is the row to sit with. Same product, same syringe: up to a year in the cheeks and up to six months in nasolabial folds. A clinic running one recall interval per product is already wrong before it starts.

Series treatments are not single events

Laser, microneedling and peels are sold as courses and forgotten as courses, and the published record is thinner than most clinics assume.

Treatment	What is actually published
Laser hair removal	FDA-cleared device labeling states no duration, no session count and no interval. It refers only to "a treatment regime" without defining it. AAD publishes 2 to 6 treatments at 4 to 6 week spacing, then open-ended maintenance
Microneedling	The FDA study supporting the first cleared device used treatments on day 1, day 30 and day 60, with follow-up to 6 months after the last one. No durability figure exists beyond that. AAD publishes 3 to 5 treatments every 2 to 4 weeks, then an annual maintenance visit
Chemical peels	No manufacturer or professional body publishes a duration of effect at all. ASDS publishes retreatment intervals only: light peels every 1 to 4 weeks, medium-depth every 6 to 12 months

The operational consequence is the same for all three: the revenue is in the series, and the series has a spacing. A client who completes visit two of five and is never booked for visit three has not churned in any sense your reporting will catch. She has an unfinished course and a clinic that stopped asking.

The number that appears in no label

Here is the gap, stated as plainly as we can.

The fade dates above are knowable. Some are printed in FDA labeling, some are published by manufacturers, some come from professional bodies. A clinic can build a recall calendar from them in an afternoon.

What no document records is whether the appointment was made. And one FDA label accidentally shows what happens when it is not. The Directions for Use for one hyaluronic acid filler notes that after the study concluded, "subjects returned for repeat treatment at their convenience," and that the average time between the last initial treatment and repeat treatment was approximately 9 months. That is on a product whose comparable figures run to twelve months and beyond. It is one of the very few places any label records what people actually did when nobody booked them, and the answer is that they drifted.

Your clients are drifting on the same curve. The treatment stops working on a date you could have predicted, and the diary is empty on that date because nobody put anything in it.

Retention statistics in this industry that don't survive checking

Before you benchmark yourself against anything, know that several of the most-quoted numbers in med spa retention have no source at all. We went looking for the origin of each of these and could not find one.

The claim	What we found on checking
"70 to 80% rebook at checkout versus 40 to 50% when clients book themselves"	No study, sample or date behind it. It appears to be a garbled version of a real platform benchmark about rebooking within 24 hours. Do not use
"40 to 50% of new clients never come back," often credited to an industry association	No primary source. The association it is credited to publishes no first-visit-return statistic at all. Do not use
"62% is the industry average retention rate"	Traces to a case study about one three-location business. 62% was that single business's before number, not an industry average. Do not use
"68% of customers leave because they believe you don't care"	An orphan statistic. No study, methodology, sample or date has ever been produced for it. Do not use
"73% of your revenue comes from repeat patients"	A denominator swap on a real figure. The genuine 73% describes the share of patients who are repeat patients, not the share of revenue they generate
"Increasing retention 5% raises profits 25 to 95%," credited to a 2014 HBR article	Real research, routinely mis-cited. It originates with Reichheld at Bain in 1996. The range is cross-industry and was never about aesthetics

One practical tip that came out of this. Industry associations publish guest posts written by vendors on their own blogs, and those posts get quoted afterwards as association research. Check the byline before you cite anything to an association. If the author works at a software company, you are quoting that software company.

Duration claims that don't survive checking either

The same problem exists on the clinical side, and these matter more because they end up in your recall intervals and on your service pages.

The claim	What the source actually says
"Restylane lasts up to 18 months"	The 18 months was measured "from baseline following re-treatment at 4.5 or 9 months." The study injected the fold twice. The headline duration silently contains a second appointment
"Restylane Lyft lasts up to 18 months," sourced to the FDA label	The phrase does appear in that label, describing how long discoloration can persist as an adverse event. It is not a duration of correction
"The FDA label says Daxxify lasts six months"	The label contains no duration statement and no six-month claim. The figure comes from published trial medians, which is a legitimate source, just not that one
"Radiesse lasts up to 2 years"	FDA labeling states one year after the first session, with beyond that not investigated. The two-year claim is marketing, footnoted to a study where 40% of folds were improved at 30 months
"Per the BOTOX label, crow's feet last X months"	The label states a duration for frown lines only. There is no per-area figure for crow's feet, forehead or platysma bands
"A chemical peel lasts X months"	No manufacturer or professional body publishes a duration of effect for peels at all. Any specific figure is invented

The Restylane row is the one to take away, because it is the article's thesis in a single sentence: the manufacturer's own headline duration number assumes a return visit that most clinics never book.

Building a recall calendar from the label

What falls out of all this is boringly practical.

Write down the published figure for every treatment you sell, from the label where one exists and from a professional body where it does not. Note which is which.
Set the interval per product and per area, not per treatment category. Restylane Lyft alone spans six months to a year depending on where it went.
Treat series treatments as series. Book the whole course at the first visit, at the published spacing. An unfinished course is the cheapest revenue in the building.
Book the next appointment before the client leaves. Everything above is arithmetic; this is the only part that is a habit, and it is the part that fails.
Measure your own rebooking rate. Not an industry benchmark, because as the table above shows, most of the published ones are fiction. The percentage of visits that end with a future appointment on the calendar. Pull it monthly.

What your software has to do

Requirement	Why
A calendar open far enough ahead	You cannot book 16 weeks out on a calendar that opens 8 weeks out. This is the most common mechanical cause of a failed checkout rebook
Per-service recall intervals	One interval per clinic is wrong the moment you sell two products with different fade curves
The client's own history visible at checkout	Front desk needs to know what she had and when, without opening a chart
Deposits on future bookings	A future slot that costs nothing to abandon gets abandoned
Reactivation that fires on the interval	Not a monthly newsletter. A message timed to that client's treatment
Rebooking rate in reporting	The percentage of visits ending with a next appointment booked, by provider

The last one is where most clinics discover the problem is not the client. Rebooking rate almost always varies more between providers in the same clinic than it does between clinics, and nobody looks because nobody measures it.

Reminders, waitlist tools and a client app that lets someone rebook without phoning are all included in our base plan rather than sold as a marketing module, which is on our pricing page with everything else. The app matters here specifically because the rebook that did not happen at the desk can still happen at 9pm from the sofa, and we describe how that works on the client app page.

Frequently asked questions

Why do med spa clients stop coming back?

Usually not because of a decision. The treatment fades on a published schedule, no appointment was made before they left, and by the time they notice the result has gone they are out of the habit. The churn event is a date on a calendar that nobody filled.

How long does Botox actually last?

The BOTOX Cosmetic prescribing information states approximately 3 to 4 months for glabellar lines, and states no duration for crow's feet, forehead lines or platysma bands. Allergan markets "up to 4 months." Both ASPS and AAD put the category at about 3 to 4 months. Individual duration varies, and this is a report of what those documents say rather than clinical guidance.

What is a good rebooking rate for a med spa?

We are not going to give you a benchmark, because most of the published ones in this industry cannot be traced to a source. Measure the percentage of your own visits that end with a future appointment booked, break it down by provider, and improve it against last month. That comparison is real and the industry averages mostly are not.

Does booking the next appointment at checkout actually work?

The widely quoted figures comparing checkout rebooking to client-initiated booking have no traceable source, so we will not repeat them. What is documented is the alternative: one FDA label records that when patients were left to return at their own convenience, the average gap was about nine months on a product whose published duration runs to a year or more.

How far ahead should my calendar be open?

Far enough to book the longest interval you sell. If you offer fillers with published figures at 12 to 24 months, an eight-week calendar cannot take that booking, and the front desk will stop trying.

What should I send a client after a treatment?

Time it to that treatment rather than to your marketing calendar. A message that arrives on a generic monthly schedule is a newsletter. A message that arrives as a specific client's result is fading is a reminder, and the two perform nothing alike.

Do memberships improve retention?

They change the mechanism, by giving the client a reason to return that is not solely how they feel about the last result. They also create a delivery obligation and a liability, which is worth understanding before launching one. We covered the economics in how to price a med spa membership program.

Why do so many med spa retention statistics disagree?

Because a lot of them were never measured. When we traced the most-quoted figures, one came from a single business's case study, one was a garbled version of a real platform benchmark, one swapped share of patients for share of revenue, and one has no identifiable study behind it at all. Ask for the sample, the year and the link before you believe any number in this category, including ours.